Tech Company Financing Transactions
BiO2 Medical Funding Round
On 3/28/2012, BiO2 Medical raised $13.7 million in funding from Incyte Venture Partners and Texas Emerging Technology Fund.
Transaction Overview
Company Name
Announced On
3/28/2012
Transaction Type
Venture Equity
Amount
$13,700,000
Round
Undisclosed
Proceeds Purpose
BiO2 Medical said in a statement that it is "well on its way" to commercializing a device called the Angel Catheter, which is designed to prevent potentially fatal pulmonary embolisms from occurring by trapping blood clots before they reach the lung.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4670 Table Mountain Dr.
Golden, CO 80403
USA
Golden, CO 80403
USA
Phone
Website
Email Address
Overview
BiO2 Medical has created the Angel Catheter to protect critically ill patients from acute Pulmonary Embolism (PE). The innovative design incorporates a retrievable Inferior Vena Cava (IVC) filter, permanently attached to a triple lumen central venous catheter.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Banas
Chief Medical Officer
Luis Angel
Controller
Joseph Piercy
VP - Finance
Chad Frederickson
VP - R & D
Jeff Steinmetz
VP - Regulatory Affairs
Julie Ross
Browse more venture capital transactions:
Prev: 3/28/2012: SepSensor venture capital transaction
Next: 3/28/2012: Quarterly venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs